These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 1703232

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR, Johnson KM.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY, Chai BL, Thompson PA, Yamamoto BK.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons.
    Gudelsky GA, Nwajei EE, Defife K, Nash JF.
    Synapse; 1992 Dec; 12(4):304-11. PubMed ID: 1361248
    [Abstract] [Full Text] [Related]

  • 7. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
    Chai B, Meltzer HY.
    Neurosci Lett; 1992 Jun 08; 140(1):47-50. PubMed ID: 1383891
    [Abstract] [Full Text] [Related]

  • 8. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
    Di Matteo V, Pierucci M, Esposito E.
    J Neurochem; 2004 Apr 08; 89(2):418-29. PubMed ID: 15056285
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J, Meltzer HY.
    Brain Res; 1990 Jan 15; 507(1):138-42. PubMed ID: 2302571
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.
    Lane RF, Blaha CD, Rivet JM.
    Brain Res; 1988 Sep 20; 460(2):398-401. PubMed ID: 2852047
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice.
    Fadda P, Scherma M, Fresu A, Collu M, Fratta W.
    Synapse; 2005 Apr 20; 56(1):29-38. PubMed ID: 15700287
    [Abstract] [Full Text] [Related]

  • 18. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S, Watson E, Stanley ME.
    J Pharmacol Exp Ther; 1975 Nov 20; 195(2):265-70. PubMed ID: 1185596
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F, Chrapusta SJ, Egan MF.
    J Neurochem; 1994 Sep 20; 63(3):972-9. PubMed ID: 7914228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.